Prescription drug · ANDA
Sumatriptan Succinate NDC 63187-607
Sumatriptan succinate 100 mg/1 · Tablet · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63187-607-09 | 63187060709 | 9 BLISTER PACK in 1 CARTON (63187-607-09) / 9 TABLET in 1 BLISTER PACKMarketed from Dec 1, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sumatriptan Succinate
- Generic name (nonproprietary)
- sumatriptan succinate
- Active ingredients
- Sumatriptan succinate — 100 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 076847
- Marketing start
- Listing expires
- Other FDA classes
- Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
- Identifiers
- Product ID 63187-607_11962982-e9c2-4dca-a018-1573c6b43ad8SPL ID 11962982-e9c2-4dca-a018-1573c6b43ad8SPL set ID d9c78ac5-7328-4204-8f66-96606d7db5c3RxCUI 313160UNII J8BDZ68989
- Pharmacologic class
- Serotonin-1b and Serotonin-1d Receptor Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463187060709followed by a unit qualifier and the quantityPackage 63187-0607-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Sumatriptan tablets are indicated for the acute treatment of migraine attacks with or without aura in adults. Sumatriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS ). Safety and effectiveness of sumatriptan tablets have not been established for cluster headache, which is present in an older, predominantly male population.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 076847
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sumatriptan Succinate | Sumatriptan succinate 25 mg/1 | TabletOral | Proficient Rx LP | 63187-617 |
| Sumatriptan Succinate | Sumatriptan succinate 50 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-4562 |
| Sumatriptan Succinate | Sumatriptan succinate 100 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-2283 |
| Sumatriptan Succinate | Sumatriptan succinate 25 mg/1 | TabletOral | Dr. Reddy's Laboratories Limited | 55111-291 |
| Sumatriptan Succinate | Sumatriptan succinate 50 mg/1 | TabletOral | Dr. Reddy's Laboratories Limited | 55111-292 |
| Sumatriptan Succinate | Sumatriptan succinate 100 mg/1 | TabletOral | Dr. Reddy's Laboratories Limited | 55111-293 |
| Sumatriptan Succinate | Sumatriptan succinate 50 mg/1 | TabletOral | Asclemed USA, Inc. | 76420-093 |
| Sumatriptan Succinate | Sumatriptan succinate 50 mg/1 | TabletOral | Proficient Rx LP | 63187-049 |